Scientific interest in conjugated linoleic acid (CLA) started in 1987 when Michael Pariza's team of Wisconsin University observed its inhibitory effects on chemically induced skin tumors in mice. Numerous studies have since examined CLA's role in cancer, immune function, oxidative stress, atherosclerosis, lipid and fatty acids metabolism, bone formation and composition, obesity, and diabetes. Still it's not clear yet either through which mechanisms CLA produces its numerous metabolic effects.
CLA is a collective term given to a group of 28 polyunsaturated fatty acids, geometric and positional isomers of linoleic acid (9c, 12c-18:2). It has the same carbon chain length as linoleic acid, but with conjugated double bonds, rather then methylene separated carbon atoms. Conjugated bonds are separated by a single bond with carbon instead of by two or more bonds. They may present themselves in the cis or trans configuration (1 ) . We know a good number of CLA' s geometrical or positional isomers, but the prevailing isomer in nature and in food is CLA c9t I I, also known as rumenic acid as it can be found in ruminant meat or dairy products. The majority of experimental trials on animals and humans use mixtures of synthetically prepared 90% pure oils. An isomer mixture 42% CLA c9t I I t9c I I and 43 % CLA t l Oc I 2is usually used, the rest is subdivided among other isomers. Few studies have made use of natural extracted oil or highly purified isomers, due to the high costs and difficult availability (2) .
Sources of CLA
CLA of natural origin is primarily made by an anaerobic microrganism of ruminants, Butyrivibrio Fibrisolvens. CLA isomers are intermediates in the biohydrogenation of linoleic acid to stearic acid. During this process, vaccenic acid (II trans 18: I) is also formed in organisms with D9 desaturases. These acids are absorbed with other dietary fatty acids in the small intestine, re-esterified and put into circulation. However, some authors consider that humans also have considersble endogenous synthesis of CLA (3). differences observed may be due to the methods of analyses, the types of animals and their ages, their dietary regimen or the season (4) . For instance Australian cattle are fed on grass rich in polyunsaturated fatty acids (PUFA) which might explain why they show a higher content of CLA than American cattle mainly fed on cereals. Also ruminant meat show higher contents of CLA than non ruminant (5) . Moreover it is not known yet whether the above differences may be caused by bacterial flora. Obviously CLA levels are higher in fatty meats than in lean meats, while it seems to be no difference between intermuscular and subcutaneous fat. Not even the different cuts of bovine meat show significant differences in CLA contents (4) .
From the data provided by the German Nutrition Survey and the results of analysis of CLA contents in food, the average intake of isomer c9t I I seems to be 0.35 g/day for women and 0.43 g/day for men. One fourth of these quantities comes from meats and derivative products (6) .
Contents oj CLA in cheeses
The content of CLA present in cheese is function of the ageing duration, processing temperature, season, location and kind of grazing. Generally speaking, the contents of CLA in cheese range between 0.4% and 0.6% (of fat weight). An analysis of the composition of Greek cheeses produced with goat or sheep milk, mainly feta, showed much higher contents of CLA than other cheeses produced with cow milk, such as mature Swiss cheeses. The final CLA content is not dependent by the quantity of linoleic acid or other PUFA present in milk at the beginning of the processing (7) . Many trials have been performed on different types of cheese (8, 9) . In one of these, samples of Emmenthal cheese were taken at different phases of processing: raw milk, pasteurised/ultrafiltrated milk, cheese after 7 days of ripening, milk after 20 days of ageing and final cheese with no changes in the CLA content (10) .
Effects oj cooking, processing and storage on CLA content
Microwaving or frying don't seem to cause a decrease in CLA content which instead resulted to be increased after grilling rib-eye, sirloin, T-bone and ground beef to an internal temperature of 80°C (4) . Similarly, the expected oxidative damage usually occurring in refrigerated storage, did not influence CLA stability in ground beef (4) . Other trials were performed to assess the possibility to enrich natural CLA content of natural products such as milk or eggs, by supplementing vegetable oils in productive animal's feeding (I I). Such dairy products contained lower levels of saturated fatty acids in comparison to the original foods. Consequently, these products could qualify as "functional foods" if beneficial effects on human health status were adequately demonstrated (12) .
CLA and body composition: fat mass reduction and lean body mass increase
The majority of available data regarding the relation between body composition and CLA comes from studies performed on animal models (mice, rats, pigs, chickens, rabbits, hamsters) and show a common effect of fat mass reduction, which seems to be modulated differently in various tissues (13) (14) .
Studies performed on non-obese mice showed that retroperitoneal and epididymal white adipose tissue (W AT) or black adipose tissue (BAT) may be more sensitive to CLA mediated reduction (15) . On the contrary, experiments on obese Zucker rats (13) showed increased adipose tissue; however, the same was not true for diabetic Zucker rats (16) . CLA consumption for more then 8 months exerted a Iipodystrophic effect on female rats, with complete black adipose tissue ablation, an increased hepatic fat accumulation and at last the development of insulin resistance. The antiadiposity effect was independent from the previous level of fat and from fat intake; besides it seemed to be isomer-specific (13) .
There was a bigger decrease in fat mass and in modulating gene expression in preadipocytes 3T3-L1 in culture, in the case of CLA tlOcl2 ( 17) .
In many studies, CLA showed a positive influence on lean body mass (LBM); in one study, in particular, a bigger increase was observed in male rat pups in comparison with female pups (18) . In another study performed on Sprague-Dawly rats, the CLA effect was visible only on decreased triglyceride levels and non-esterified fatty acids, while fat mass was unchanged (19) .
Diets containing CLA administered to mice, enhanced metabolic rate, increased oxygen consumption and significantly increased lipid oxidation, either in muscle or in adipose cells (20) .
Park et al. demonstrated that dietary CLA significantly augmented the carnitinpalmytoil transferase (CPT) activity either in fat pads or in skeleton muscle, but not in the liver of mice (18) .
In adipocytes 3T3-L1, CLA t I Oc12 reduced the LPL activity and the intracellular glycerol and triglycerides concentration, but increased the hormone-sensitive Iipases (HSL) activity (21) . As previously demonstrated, the ratio between c9t12 and t I Oc12 varies according to the tissues. For this reason, it has been hypothesized that if the different isomers exert distinct responses in different tissues, then the CLA effect on FM may be separate from CLA effect on LBM (22) .
Studies Oil humans
Some studies have demonstrated a decrease in FM and an increase in LBM (23) . A Norwegian study examined the effects of CLA on FM, LBM, body weight reduction and serum lipids, 52 healthy men and women, who were all administered different amounts of CLA (1.7, 3.4, and 6.8 g/ day). None of the groups showed a significant reduction of body weight or BMI after 12 month's treatment, but different FM values were registered between the CLA group and the placebo group. Among those consuming CLA, the FM was more significantly decreased in the 3.4 g/day and 6.8 g/ day groups. No increase in LBM was registered in the placebo group; instead, a significant increase was observed in the 6.8 g/day group (between I st and 12 th week). In all the CLA treated groups, significant reductions in serum lipids (total colesterol, LDL and HDL-coletserol) were seen (24) . Other studies using dosages of 3 g/day also showed no beneficial effect on weight, FM (25), energy expenditure, or fat oxidation (26) . On the contrary, no effect of CLA on FM was observed on weight lifters who exhibited a low percentage of FM (14%) (24) .
CLA and adipogenesis
CLA has been shown to inhibit the growth and differentiation in culture of preadipocytes in triglyceride rich mature adipocytes, to decrease the levels of two critical transcriptional factors: PPAR-y (involved in modulation of lipid metabolism) and C/EBPex (CCATT enhancer binding protein alpha), and of aP2, a fatty acid binding protein present in adipose tissue (27) (28) .
This effect is distinguished from the one' caused by lipid peroxidation (21) and it is reversible by administering linoleic acid at increasing dosages, as it was verified in human hepatic and adipose cells (29) .
CLA and glucose metabolism
A Swedish group observed a reduction in abdominal adipose tissue when 25 obese subjects were administered 4.2 g/day CLA for 4 weeks; sagittal abdominal diameter (SAD) decreased significantly while other metabolic and parameters were unaltered (31) . Subsequently, Belury reported that 8 months administration of 6.0 g/day to diabetic subjects (NIDD) who kept their dietary habits, produced significant reduction of glycemia, plasma leptin, BMI and body weight (2) .
Insulin resistance (19%) and glycemia (4%) in obese subjects affected by metabolic syndrome, to whom a dosage of 3.4 g/day of CLA was administered for 12 weeks (30) . The mechanisms through which this effect can be explained are not quite clear. It has been proposed from animal studies that isomer t I Oc12 could inhibit small insulin sensitive new adipose cells, through a process involving PPAR-y,or that the increased intra-muscular fat content could reduce the cell membrane functionality (32) .
CLA and leptin
A study on healthy women examined the effects of 3 g/day of CLA for 64 days on Ieptin, insulin, glucose and lactate levels, on appetite (33) . While during treatment, glucose and lactate didn't show any alteration, insulinemia showed significant increasing trend towards the end of the treatment. Even in absence of any alteration in FM, leptin levels significantly diminished in the first 7 weeks, to return to basal levels during the last 2 weeks of the study. Parameters related to appetite, measured during leptin decrease didn't show any differences between basal determination and CLA supplementation.
CONCLUSIONS
Given the above, marketing gCL as a overthe-counter weight losing agent is not justified. Actually, mixtures on sale contain between 20-50% of isomer t I Oc I 2, which has demonstrated to induce insulin resistance and dyslipidernia in susceptible subjects. Multiple investigations will be needed to explain class pleiotropic effects (34) .
It would be interesting to see if administering bigger doses of this compound, at least equal to the dosage supposed to be able to promote a decrease of body fat percentage in a shorter time. It would also be useful, to identify the adipose tissue most affected by CLA (23) . For instance, proton magnetic resonance spectroscopy CH-MRS) has been recently used to relate intramyoceIlular lipid accumulation and insulin sensitivity in healthy subjects, even if not in obese or diabetic patients (35) . Recent research has established that intracellular fat accumulation in the skeleton muscle is inversely correlated to insulin sensitivity and that the depletion of the same intraceIlular fatand not interfibriIlar or perivascular is capable to correct insulin resistance (36) . Moreover, insulin resistance in prone subjects may be due to the isomer t I Oc I 2 metabolite's inflammatory activity, among many inflammatory diseases (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) . The CLA commercial mixture commonly used (50% and 50% of both isomers) still maintains an antiinflammatory activity, as one isomer's activity counterbalances the other and this result might explain why Riseruss study of 2001 doesn't report diminished values of insulin activity in the CLA group (31) (32) (33) (34) .
A recent point of considerable discussion is the ratio of omega-3 and omega-6 fatty acids with their subsequent influence on membrane fluidity, erachidonic acid production and subsequent synthesis' of proinflammatory molecules. The possible contribution of CLA in this balance is to be determined.
